- Home
- ICLR vs SYF Comparison
ICLR vs SYF Comparison
Compare ICLR & SYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- SYF
- Stock Information
- Founded
- ICLR 1990
- SYF 1932
- Country
- ICLR Ireland
- SYF United States
- Employees
- ICLR N/A
- SYF N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- SYF Finance: Consumer Services
- Sector
- ICLR Health Care
- SYF Finance
- Exchange
- ICLR Nasdaq
- SYF Nasdaq
- Market Cap
- ICLR 16.4B
- SYF 19.4B
- IPO Year
- ICLR 1998
- SYF N/A
- Fundamental
- Price
- ICLR $201.39
- SYF $61.41
- Analyst Decision
- ICLR Strong Buy
- SYF Buy
- Analyst Count
- ICLR 12
- SYF 22
- Target Price
- ICLR $278.27
- SYF $66.45
- AVG Volume (30 Days)
- ICLR 913.3K
- SYF 4.3M
- Earning Date
- ICLR 02-19-2025
- SYF 01-28-2025
- Dividend Yield
- ICLR N/A
- SYF 1.63%
- EPS Growth
- ICLR 28.78
- SYF 64.74
- EPS
- ICLR 9.53
- SYF 8.55
- Revenue
- ICLR $8,281,675,999.00
- SYF $9,392,000,000.00
- Revenue This Year
- ICLR $4.00
- SYF N/A
- Revenue Next Year
- ICLR $1.37
- SYF $7.81
- P/E Ratio
- ICLR $21.18
- SYF $7.18
- Revenue Growth
- ICLR 1.99
- SYF 22.58
- 52 Week Low
- ICLR $181.51
- SYF $39.67
- 52 Week High
- ICLR $347.72
- SYF $70.93
- Technical
- Relative Strength Index (RSI)
- ICLR 54.92
- SYF 33.47
- Support Level
- ICLR $181.51
- SYF $63.31
- Resistance Level
- ICLR $203.26
- SYF $65.97
- Average True Range (ATR)
- ICLR 6.32
- SYF 2.09
- MACD
- ICLR 1.50
- SYF -0.53
- Stochastic Oscillator
- ICLR 72.45
- SYF 4.72
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About SYF Synchrony Financial
Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).